Hope springs eternal

14 May 2020

5 minute read

The COVID-19 pandemic has turned much of life upside down. Companies haven’t escaped its effects. Little meaningful has been gained on their prospects from this year’s first-quarter earnings, while second-quarter earnings growth is shaping up to be even worse. But, investors’ optimism appears intact, in the seeming belief that a full, and relatively quick, recovery next year is still on the table. Is this being too optimistic?

Better than expected earnings

In the US, companies saw their earnings contract by around 12% year-on-year in the three months to March. While broadly in line with “bottom-up” consensus, it was much better than some feared, with expectations for a figure closer to -20%. Yet, only around two-thirds of companies beat expectations, low relative to a typical quarter.

From a sector perspective, divergence was large. Consumer discretionary, energy and financials faced earnings declines of over 30%, while healthcare and technology saw growth of around 6%. In Europe, although most companies do not publish their full quarterly profit and loss account, those who have reported an average decline in earnings of about -35%. The combination of a large exposure to emerging markets and earlier lockdowns can explain the underperformance versus US companies.

Very few winners

Some companies in food retail or healthcare initially benefited from the stockpiling frenzy that preceded quarantining. But, this effect was short-lived and is likely to be followed by “payback” in the second quarter. While top-line growth has been resilient, at -1.7% in the US, many companies have incurred higher costs to keep their business running, weighing on profitability.

Companies give limited financial guidance

The swathe of companies not giving any financial guidance on their prospects was the other key feature of this earnings season. As a result, investors remain blind. For the three months to June, the consensus expects US earnings to shrink by more than 35%. For the full year, downgrades have accelerated and pushed the expected contraction to -22%.

We have very little confidence in the above numbers, especially when an analysis of around 600 earnings call by US Federal Reserve researchers showed that roughly 42% of US non-financial public companies are discussing slashing investments. At the peak of the last recession, the comparable figure was “only” 25%.

Awaiting V-shaped recovery

Despite earnings forecasts being cut at an unprecedented pace, equities have been resilient. This divergence can be explained by investors’ willingness to look past 2020 and focus on the recovery expected for 2021.

The market is anticipating earnings growth of around 30% next year, taking 2021 earnings above their 2019 levels. This belief in a V-shaped recovery was fuelled by companies’ comments highlighting improving trends in early April. But we believe the market may be reading too much into green shoots like rebounding hotel occupancy levels or more credit card swipes being seen than at the peak of the crisis.


Diversify, diversify, diversify

For the time being, we expect markets to remain disconnected from near-term fundamentals. The science around COVID-19, and finding a vaccine to it, and the hopes of an economic recovery seem to be largely driving market prospects. Yet, plenty of risks are still on the horizon, such as a possible second wave of infection, renewed lockdowns and long-lasting damage to consumer confidence.

We remain squarely focused on maintaining proper diversification in portfolios and taking advantage of the elevated volatility levels likely to persist for some time.

Related articles

Investments can fall as well as rise in value. Your capital or the income generated from your investment may be at risk.

This document has been issued by the Investments division at Barclays Private Banking division and is not a product of the Barclays Research department. Any views expressed may differ from those of Barclays Research. All opinions and estimates included in this document constitute our judgment as of the date of the document and may be subject to change without notice. No representation is made as to the accuracy of the assumptions made within, or completeness of, any modeling, scenario analysis or back-testing.

Barclays is not responsible for information stated to be obtained or derived from third party sources or statistical services, and we do not guarantee the information’s accuracy which may be incomplete or condensed.

This document has been prepared for information purposes only and does not constitute a prospectus, an offer, invitation or solicitation to buy or sell securities and is not intended to provide the sole basis for any evaluation of the securities or any other instrument, which may be discussed in it.

Any offer or entry into any transaction requires Barclays’ subsequent formal agreement which will be subject to internal approvals and execution of binding transaction documents. Any past or simulated past performance including back-testing, modeling or scenario analysis contained herein does not predict and is no indication as to future performance. The value of any investment may also fluctuate as a result of market changes.

Neither Barclays, its affiliates nor any of its directors, officers, employees, representatives or agents, accepts any liability whatsoever for any direct, indirect or consequential losses (in contract, tort or otherwise) arising from the use of this communication or its contents or reliance on the information contained herein, except to the extent this would be prohibited by law or regulation..

This document and the information contained herein may only be distributed and published in jurisdictions in which such distribution and publication is permitted.  You may not distribute this document, in whole or part, without our prior, express written permission. Law or regulation in certain countries may restrict the manner of distribution of this document and persons who come into possession of this document are required to inform themselves of and observe such restrictions.

The contents herein do not constitute investment, legal, tax, accounting or other advice. You should consider your own financial situation, objectives and needs, and conduct your own independent investigation and assessment of the contents of this document, including obtaining investment, legal, tax, accounting and such other advice as you consider necessary or appropriate, before making any investment or other decision.